Announcement of Resolutions from the First Extraordinary Shareholders' Meeting of 2026

1. Securities Code: 002020
   Securities Abbreviation: Jingxin Pharmaceutical
   Announcement Number: 2026012

Zhejiang Jingxin Pharmaceutical Co., Ltd.
Announcement of Resolutions from the First Extraordinary Shareholders' Meeting of 2026

The company and all members of the board of directors guarantee that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Important Notice:

1. There were no rejected proposals at this shareholders' meeting.
2. The meeting was held combining on-site voting and online voting.

I. Meeting Details

1. Meeting Time
   On-site meeting time: January 28, 2026, starting at 14:00.
   Online voting: The specific time for online voting through the Shenzhen Stock Exchange trading system is from 09:15 to 09:25, 09:30 to 11:30, and 13:00 to 15:00 on January 28, 2026; through the Shenzhen Stock Exchange internet voting system, online voting can be conducted at any time from 09:15 to 15:00 on January 28, 2026.
2. Meeting Location
   Conference Room on the First Floor of the Administrative Building, No. 800, Xinchang Avenue East Road, Yulin Street, Xinchang County, Zhejiang Province.
3. Meeting Method
   This meeting adopted a combination of on-site voting and online voting. The shareholders were provided with an online voting platform through the Shenzhen Stock Exchange trading system and internet voting system, allowing them to exercise their voting rights during the online voting period.
4. Meeting Convener
   The board of directors of Zhejiang Jingxin Pharmaceutical Co., Ltd.
5. Meeting Host
   Mr. Lü Gang, Chairman of the Company.
6. The convening, holding, and voting procedures of this meeting comply with relevant laws, regulations, rules, and the company's articles of association.

II. Attendance

According to the relevant provisions of the "Implementation Rules for Share Repurchase of Listed Companies on the Shenzhen Stock Exchange," shares in the special account for share repurchase do not have voting rights at the shareholders' meeting. Therefore, when calculating the total number of shares with voting rights, the number of shares in the repurchase special account should be deducted. The total number of shares with voting rights at this shareholders' meeting is 820,881,245 shares.

1. Overall Attendance
   A total of 442 shareholders and shareholder representatives attended the on-site meeting and participated in online voting, representing 359,149,777 shares with voting rights, accounting for 43.7517% of the total shares with voting rights.
2. On-site Attendance
   A total of 11 shareholders and shareholder representatives attended the on-site meeting, representing 320,747,698 shares with voting rights, accounting for 39.0736% of the total shares with voting rights.
3. Online Voting
   A total of 431 shareholders participated in online voting, representing 38,402,079 shares with voting rights, accounting for 4.6782% of the total shares with voting rights.
4. Small and Medium Investors' Attendance
   A total of 438 small and medium investors (defined as shareholders other than the company's directors, senior management, and shareholders holding more than 5% of the company's shares individually or collectively) participated in the voting, representing 41,435,643 shares with voting rights, accounting for 5.0477% of the total shares with voting rights.

The company's directors and senior management attended the meeting, and lawyers from Shanghai Jintiancheng Law Firm were present to witness the meeting and issue a legal opinion. The convening, holding, and voting procedures of this meeting comply with the "Company Law," "Stock Listing Rules of the Shenzhen Stock Exchange," "Articles of Association," and other legal regulations and normative documents.